COOPER JOHN G
SEC Form 4 insider trading activity
COOPER JOHN G has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jul 6, 2026.
On the most recent filing, COOPER JOHN G is listed as Director at ROCKWELL MEDICAL, INC. Inside the rolling window, COOPER JOHN G reported no open-market purchases and 1 open-market sale totaling $4K in RMTI.
Companies traded
Other insiders at RMTI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has COOPER JOHN G made?
COOPER JOHN G has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does COOPER JOHN G trade?
COOPER JOHN G has filed SEC Form 4 disclosures for 1 company, including RMTI.
When was COOPER JOHN G's most recent SEC Form 4 filing?
COOPER JOHN G's most recent SEC Form 4 filing on Tracefour is dated Jul 6, 2026.
What is COOPER JOHN G's total buy and sell value in the current window?
Inside the rolling retention window, COOPER JOHN G bought $0 and sold $4K based on SEC Form 4 filings.
What was COOPER JOHN G's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,079 RMTI shares on 2025-11-18, worth $4K, per SEC Form 4 filings.